Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001562180-22-001654
Filing Date
2022-02-18
Accepted
2022-02-18 21:55:44
Documents
1
Period of Report
2018-12-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4/A  
1 PRIMARY DOCUMENT primarydocument.xml 4/A 4587
  Complete submission text file 0001562180-22-001654.txt   5931
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RELYPSA, INC. 700 SAGINAW DR. REDWOOD CITY CA 94063
Business Address
Butler John P. (Reporting) CIK: 0001591467 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36352 | Film No.: 22654717